Saturday, August 22, 2015 6:53:59 AM
"Not an independent clinical trial"
Actually, Dr Jiminez did conduct an independent clinical trial and was impressed enough with the results that he became a stockholder. He indeed was a stockholder at the time of presentation of the study results at meeting of EASD in Barcelona Spain. That does not make the trial results invalid. At any conferences I attend medical research presenters are required to disclose any financial interests pertinent to the presentation. That way, the audience can make their own assessment of the information presented.
Personally, I view the Doctors investment as a positive thing, it reminds me of a previous men's clothing store commercial where the owner said he liked the product quality so much that he bought the company.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM